Perspective Therapeutics
Manufacturing · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2401 Elliott Ave Ste 320, Seattle, Washi...Phone Number
(206) 676-0900Revenue
-Stock Symbol
CATXIndustry
About Perspective Therapeutics
Perspective Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing innovative radiopharmaceutical therapies for the treatment of cancer. The company specializes in targeted alpha-particle therapy, an emerging field of precision oncology that combines advanced radiochemistry with molecular targeting technologies to deliver highly localized radiation directly to cancer cells while minimizing damage to surrounding healthy tissue. Through scientific innovation and clinical research, Perspective Therapeutics aims to improve treatment outcomes for patients with difficult-to-treat cancers by creating therapies capable of delivering potent therapeutic effects with greater precision than conventional radiation approaches.Explore more
SIC Code 28,283NAICS Code 54,541Ticker NYSE: CATXShow morePerspective Therapeutics Org Chart
Compare Similar Companies to Perspective Therapeutics
Compare insights from companies similar to Perspective Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Perspective Therapeutics Tech Stack
A closer look at the technologies used by Perspective Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Perspective Therapeutics
Sign Up For FreeTo access detailed company insights
Perspective Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing innovative radiopharmaceutical therapies for the treatment of cancer. The company specializes in targeted alpha-particle therapy, an emerging field of precision oncology that combines advanced radiochemistry with molecular targeting technologies to deli... Read More
